Cancer Statistics, 2002

@article{Jemal2002CancerS2,
  title={Cancer Statistics, 2002},
  author={Ahmedin Jemal and Andrea Thomas and Taylor Murray and Michael J. Thun},
  journal={CA: A Cancer Journal for Clinicians},
  year={2002},
  volume={52}
}
Every year the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival, using National Cancer Institute (NCI) incidence and National Center for Health Statistics (NCHS) mortality data. Incidence and death rates are age adjusted to the 1970 US standard population. It is estimated that 1,284,900 new cases of cancer will be diagnosed and 555,500… Expand
Prostate Cancer Incidence and Mortality Rates and Trends in the United States and Canada
TLDR
Recent incidence patterns observed between the U.S. and Canada suggest a strong relationship to prostate-specific antigen (PSA) test use, and clinical trials are required to determine any effects of PSA test use on prostate cancer and overall mortality. Expand
Evaluating quality of life in cancer survivors
TLDR
Understanding how individuals who are cancer survivors manage the impact of cancer and experience the transformation of their lives is critical for health care professionals committed to assisting cancer patients and survivors in their recovery, for payers of health care, and for those engaged in policy regarding health insurance, employment, and disability-related rights of these many survivors. Expand
Screening for Prostate Cancer: An Update of the Evidence
TLDR
The burden of prostate cancer falls disproportionately on men who are older or black, and the incidence rate is approximately 60% higher and mortality rate is twofold higher in black men than in white men. Expand
The Full Potential of Breast Cancer Screening Use to Reduce Mortality has not yet been Realized in the United States
TLDR
Although there has been an increase in early-stage breast cancers (in situ and T1 tumors), the prerequisite decline in late-stage cancers has not yet occurred in the United States — a pattern that was observed in European studies. Expand
Screening for Prostate Cancer: An Update of the Evidence for the U.S. Preventive Services Task Force
TLDR
A systematic review of the evidence on screening for prostate cancer found no direct evidence connecting screening and reduced mortality, and searched for indirect evidence on the yield of screening, the efficacy and harms of various forms of treatment for early prostate cancer, and the costs and cost-effectiveness. Expand
A geographic analysis of prostate cancer mortality in the United States, 1970–89
TLDR
The patterns observed could not be attributed to selected demographic or socioeconomic characteristics but should provide leads for further study into the risk factors and the medical or reporting practices that may contribute to geographic variation in mortality from prostate cancer. Expand
The Epidemiology of Lung Cancer
TLDR
This chapter will endeavor to highlight lung cancer incidence and mortality worldwide, identify changing trends in the lung cancer epidemic, and discuss the numerous etiologies of this deadly cancer. Expand
Lung and Pleural Cancers
TLDR
The survival rate is poor, largely because lung cancer is usually diagnosed at an advanced stage, and new diagnostic and treatment strategies are needed if an impact is to be made on the survival of patients with lung cancer. Expand
A new paradigm in breast cancer prevention
TLDR
The incurability of the disease, in association with the worldwide increase in incidence indicates that primary prevention is the ultimate goal for breast cancer control. Expand
Molecular biology and early diagnosis in lung cancer.
TLDR
The need for new strategies for screening and early detection are critical to reducing the burden of this dread disease that is self inflicted by corporate greed that pervades the authors' societies. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 53 REFERENCES
Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends.
TLDR
Overall cancer incidence and death rates continued to decline in the United States and future progress will require sustained improvements in cancer prevention, screening, and treatment. Expand
Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.
TLDR
The decline in the incidence of distant stage disease holds the promise that testing for prostate-specific antigen may lead to a sustained decline in prostate cancer mortality, however, population data are complex, and it is difficult to confidently attribute relatively small changes in mortality to any one cause. Expand
An adjustment to the 1997 estimate for new prostate cancer cases
TLDR
It is now estimated that fewer than 210,000 new cases of prostate cancer may be diagnosed in 1997 than previously estimated. Expand
Delineation of prognostic biomarkers in prostate cancer
TLDR
Two genes—hepsin, a transmembrane serine protease, and pim-1, a serine/threonine kinase—are assessed at the protein level using tissue microarrays consisting of over 700 clinically stratified prostate-cancer specimens and linked clinical and pathology data are established. Expand
Gene expression profiling of clear cell renal cell carcinoma: Gene identification and prognostic classification
  • M. Takahashi, D. Rhodes, +4 authors B. Teh
  • Biology, Medicine
  • Proceedings of the National Academy of Sciences of the United States of America
  • 2001
TLDR
The results suggest that two molecularly distinct forms of ccRCC exist and that the integration of expression profile data with clinical parameters could serve to enhance the diagnosis and prognosis ofccRCC. Expand
Gene-expression profiles in hereditary breast cancer.
TLDR
Significantly different groups of genes are expressed by breast cancers with BRCA1 mutations and breast cancersWith BRCa2 mutations, the results suggest that a heritable mutation influences the gene-expression profile of the cancer. Expand
Predicting the clinical status of human breast cancer by using gene expression profiles
TLDR
Bayesian regression models that provide predictive capability based on gene expression data derived from DNA microarray analysis of a series of primary breast cancer samples are developed and the utility and validity of such models in predicting the status of tumors in crossvalidation determinations are assessed. Expand
Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling.
TLDR
Gene expression analysis of prostate tissues should help to disclose the molecular mechanisms underlying prostate malignant growth and identify molecular markers for diagnostic, prognostic, and therapeutic use. Expand
Molecular portraits of human breast tumours
TLDR
Variation in gene expression patterns in a set of 65 surgical specimens of human breast tumours from 42 different individuals were characterized using complementary DNA microarrays representing 8,102 human genes, providing a distinctive molecular portrait of each tumour. Expand
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
TLDR
Survival analyses on a subcohort of patients with locally advanced breast cancer uniformly treated in a prospective study showed significantly different outcomes for the patients belonging to the various groups, including a poor prognosis for the basal-like subtype and a significant difference in outcome for the two estrogen receptor-positive groups. Expand
...
1
2
3
4
5
...